Department of Urology, Lanzhou University Second Hospital, Lanzhou, 730000, China.
Gansu Province Clinical Research Center for Urology, Lanzhou, 730000, China.
World J Surg Oncol. 2023 Sep 11;21(1):285. doi: 10.1186/s12957-023-03164-w.
To compare the surgical effects of lateral transperitoneal approach (LTA) and posterior retroperitoneal approach (PRA) for pheochromocytoma of different sizes.
Data on patients with pheochromocytoma from 2014 to 2023 were collected from our hospital. According to different surgical approaches and tumor size, all patients were divided into four groups: tumor size < 6 cm for LTA and PRA and tumor size ≥ 6 cm for LTA and PRA. We compared these two surgical methods for pheochromocytoma of different sizes.
A total of 118 patients with pheochromocytoma underwent successful laparoscopic surgery, including PRA group (n = 80) and LTA group (n = 38). In tumor size < 6 cm, the outcomes were no significant difference in LTA and PRA. In tumor size ≥ 6 cm, there was a significant difference in operation time (214.7 ± 18.9 vs. 154.3 ± 8.2, P = 0.007) and intraoperative blood loss (616.4 ± 181.3 vs. 201.4 ± 45.8, P = 0.037) between LTA and PRA.
LTA and PRA were performed safely with similar operative outcomes in patients with pheochromocytoma size < 6 cm. While both LTA and PRA were executed with a commendable safety profile and comparable operative results in patients afflicted by pheochromocytomas < 6 cm, the PRA technique distinctly showcased advantages when addressing large-scale pheochromocytomas (≥ 6 cm). Notably, this manifested in reduced operative time, diminished intraoperative blood loss, decreased hospitalization expenses, and a paucity of procedural complications.
比较不同大小的嗜铬细胞瘤经侧腹腔径路(LTA)和后腹腔径路(PRA)手术的效果。
收集我院 2014 年至 2023 年嗜铬细胞瘤患者的数据。根据不同的手术方法和肿瘤大小,将所有患者分为四组:肿瘤大小<6cm 行 LTA 和 PRA,肿瘤大小≥6cm 行 LTA 和 PRA。比较两种手术方法治疗不同大小嗜铬细胞瘤的效果。
共 118 例嗜铬细胞瘤患者成功接受腹腔镜手术,其中 PRA 组(n=80)和 LTA 组(n=38)。在肿瘤大小<6cm 时,LTA 和 PRA 的结果无显著差异。在肿瘤大小≥6cm 时,手术时间(214.7±18.9 比 154.3±8.2,P=0.007)和术中出血量(616.4±181.3 比 201.4±45.8,P=0.037)有显著差异。
LTA 和 PRA 治疗肿瘤大小<6cm 的嗜铬细胞瘤是安全的,手术结果相似。在肿瘤大小<6cm 的患者中,LTA 和 PRA 均能安全实施,且手术结果相当,但在处理大型嗜铬细胞瘤(≥6cm)时,PRA 技术具有明显优势。值得注意的是,该技术在手术时间、术中出血量、住院费用和手术并发症方面均有优势。